Finance

Lists
Why is CTX down 7,50%?
Dive Deeper
CTX:WSE
Captor Therapeutics SA
59,20 PLN
-7,50%
(-4,80) 1D
12 հոկ, 13:27:20 GMT+2  ·   PLN
All symbols
SymbolPriceChange% Change
Generating top insights for CTX...
Open
64,10 PLN
High
64,40 PLN
Low
59,20 PLN
Mkt. cap
376,12 մլն
Avg. vol.
3,27 հզր
Volume
8,21 հզր
52-wk high
89,20 PLN
52-wk low
37,70 PLN
EPS
-7,77 PLN
Shares outstanding
6,35 մլն
No. of employees
82
Open
64,10 PLN
High
64,40 PLN
Low
59,20 PLN
Mkt. cap
376,12 մլն
Avg. vol.
3,27 հզր
Volume
8,21 հզր
52-wk high
89,20 PLN
52-wk low
37,70 PLN
EPS
-7,77 PLN
Shares outstanding
6,35 մլն
No. of employees
82
News stories
From web sources and news partners
About Captor Therapeutics SA
CEO-
Employees82
Founded2015
Headquarters-
Sector-
Last report
15 սեպ, 2026 թ.
Fiscal period
Q2 2026
- / -
Revenue / Est. (PLN)
1,63 մլն / 1,50 մլն
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in PLN
Loading Previous Earnings...
Revenue
Net income
All values in PLN
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
-
44,00 հզր
328,00 հզր
1,63 մլն
Cost of goods sold
-2,02 մլն
-
-
173,00 հզր
Cost of revenue
-2,02 մլն
-
-
173,00 հզր
Research and development expenses
14,74 մլն
9,82 մլն
10,56 մլն
13,78 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,37 մլն
2,53 մլն
1,92 մլն
2,25 մլն
Operating expense
13,83 մլն
10,40 մլն
11,59 մլն
14,39 մլն
Total operating expenses
11,81 մլն
10,40 մլն
11,59 մլն
14,56 մլն
Operating income
-11,81 մլն
-10,36 մլն
-11,26 մլն
-12,93 մլն
Other non operating income
1,00 հզր
-8,00 հզր
-
-
EBT including unusual items
-11,48 մլն
-10,05 մլն
-11,35 մլն
-11,39 մլն
EBT excluding unusual items
-11,48 մլն
-10,12 մլն
-11,35 մլն
-11,39 մլն
Income tax expense
-
-
27,00 հզր
-
Effective tax rate
-
-
-0,24%
-
Other operating expenses
-2,27 մլն
-1,94 մլն
-893,00 հզր
-1,64 մլն
Net income
-11,48 մլն
-10,05 մլն
-11,38 մլն
-11,39 մլն
Net profit margin
-
-22 831,82%
-3 467,99%
-696,88%
Earnings per share
-
-
-
-
Interest and investment income
391,00 հզր
303,00 հզր
39,00 հզր
1,63 մլն
Interest expense
-61,00 հզր
-75,00 հզր
-67,00 հզր
-57,00 հզր
Net interest expenses
330,00 հզր
228,00 հզր
-28,00 հզր
1,57 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-10,81 մլն
-9,53 մլն
-10,36 մլն
-12,04 մլն
Gain or loss from assets sale
-682,00 հզր
-
-
-128,00 հզր
AI content may include mistakes. Learn more
Google Apps